New drug SEP-479 enters first human safety tests
Knowledge-focused
Recruiting now
This early-stage study is testing a new drug, SEP-479, in 150 healthy adults aged 21 to 60. The main goal is to check if the drug is safe and how the body processes it. Participants will take single or multiple doses of the drug or a placebo. This study does not aim to treat any …
Phase: PHASE1 • Sponsor: Septerna, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC